Mode
Text Size
Log in / Sign up

CSTE and CDC develop surveillance case definition for MIS-C associated with SARS-CoV-2How do doctors define the dangerous COVID-related illness in children?

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note: CSTE/CDC MIS-C definition is for surveillance, not clinical diagnosis.

The Council of State and Territorial Epidemiologists (CSTE) and Centers for Disease Control and Prevention (CDC) have developed a surveillance case definition for Multisystem Inflammatory Syndrome in Children (MIS-C) associated with SARS-CoV-2 infection. This definition was created for use in the United States to standardize reporting and monitoring of this condition. The publication describes the development of this definition but does not report on a specific study type, phase, population, sample size, or validation results.

No intervention, comparator, or clinical outcomes are reported, as this appears to be a methodological publication focused on establishing surveillance criteria rather than reporting clinical trial or observational study results. The document does not contain data on treatment effects, patient outcomes, or comparative effectiveness of different approaches to MIS-C management.

Safety and tolerability information, adverse events, and discontinuation rates are not reported, as this publication does not describe a therapeutic intervention. Key limitations include the absence of validation data, performance characteristics (sensitivity, specificity), and information about how this definition was developed or tested in clinical populations. The practice relevance is limited to public health surveillance; clinicians should consult clinical guidelines rather than relying solely on surveillance definitions for diagnosis and management decisions.

When a new and frightening illness appears in children, doctors need a shared language to identify it. This report details the creation of that shared language—the official case definition for Multisystem Inflammatory Syndrome in Children (MIS-C). MIS-C is a serious condition where different parts of a child's body become inflamed, and it has been associated with prior SARS-CoV-2 infection, the virus that causes COVID-19.

The work was done by experts from the Council of State and Territorial Epidemiologists (CSTE) and the Centers for Disease Control and Prevention (CDC) in the United States. Their goal was to create a clear, standardized set of criteria that doctors and health departments across the country can use to decide if a sick child has MIS-C. This is crucial for accurate tracking and understanding of the illness.

It's important to know what this report is and isn't. It defines the illness; it does not report on how many children have had it, what causes it, how to treat it, or how well children recover. The report itself does not include any data on patient outcomes, safety, or the effectiveness of treatments. The case definition is a tool for public health surveillance, providing a consistent starting point for counting and investigating cases.

What this means for you:
Health officials have created a standard definition to help doctors identify MIS-C in children.

Study Details

EvidenceLevel 5
PublishedDec 2022
View Original Abstract ↓
This report describes the development of CSTE/CDC MIS-C surveillance case definition.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.